AAV Production in HEK293 Cells: A Lab Protocol | NIIMBL

Added:

The Baculovirus/Sf9 Insect Cell Platform as a Scalable Alternative

While transient transfection of HEK293 cells is a standard protocol for AAV production, it faces significant limitations in scalability and cost due to the high volume of plasmid DNA required. A major alternative in gene therapy manufacturing is the Baculovirus/Sf9 insect cell expression system. This platform offers superior scalability for large-scale bioreactors and higher vector yields without the need for expensive transfection reagents. However, proponents of the HEK293 system argue that mammalian cells produce AAV vectors with superior post-translational modifications and higher specific infectivity compared to those produced in insect cells, which can sometimes exhibit a higher ratio of empty-to-full capsids.

Basic biology of Adeno-Associated Virus (AAV) and its structure, genome, and role as a gene delivery vector.
Fundamental principles of mammalian cell culture, specifically the maintenance and scaling of suspension HEK293 cell lines.
The concept of transient transfection and the triple-plasmid transfection system commonly used for AAV production.
Basic laboratory techniques in biochemistry, such as cell lysis methods and fundamental chromatography principles.
Analytical characterization methods for AAV vectors, including qPCR/ddPCR for genome titer and ELISA for physical capsid titer.
Quality control standards and purity analysis of viral vectors using techniques like silver staining, SDS-PAGE, or transmission electron microscopy (TEM).
Process scale-up strategies to transition from shake flasks to controlled bioreactor systems for industrial viral vector manufacturing.
Regulatory pathways and Good Manufacturing Practices (GMP) required for producing clinical-grade gene therapy products.
2.2K views25likes25:13@innovatebioOriginal Release: 2021-12-04

This video demonstrates a complete protocol for producing Adeno-Associated Virus (AAV) type 2 particles in HEK293 suspension cells, covering cell culture expansion, triple transfection with three plasmids (vector, rep, and cap), cell lysis, centrifugation, and purification using chromatography with specific buffer systems (binding, wash, and elution buffers). The process requires BSL-2 containment, uses Thermo Fisher's HEK293 cells designed for suspension growth, and produces viral particles that must be separated from empty and partially filled capsids for therapeutic applications.